NCT02741518 - Fecal Microbiota Transplantation (FMT) & Adiposity / Obesity

Background

Research conducted on mice has indicated that the gut microbiota may play a role in contributing to obesity. This occurs through the anorexigenic gut hormone known as glucagon-like peptide 1 (GLP1) and bile acids, both of which have an impact on lipid metabolism (1).

Study overview

NCT02741518 - Fecal Microbiota Transplantation (FMT) & Adiposity / Obesity is a randomized clinical phase I/II treatment trial studying Fecal Microbiota Transplantation (FMT) or placebo in patients with Adiposity / Obesity (BMI of 35kg/m^2 or higher)

Primary outcome measures

Adverse Event Frequency

Results

• Adverse Events: …